Renne, C., Martin-Subero, J. I., Eickernjager, M., Hansmann, M. L., Kuppers, R., Siebert, R. & Brauninger, A. (2006). Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma. Am J Pathol 169, 655-664. Reux, I., Fil<strong>le</strong>t, A. M., Agut, H., Katlama, C., Hauw, J. J. & LeHoang, P. (1992). In situ <strong>de</strong>tection of human herpesvirus 6 in retinitis associated with acquired immuno<strong>de</strong>ficiency syndrome. Am J Ophthalmol 114, 375-377. Reymen, D., Naesens, L., Balzarini, J., Holy, A., Dvorakova, H. & De C<strong>le</strong>rcq, E. (1995). Antiviral activity of se<strong>le</strong>cted acyclic nuc<strong>le</strong>osi<strong>de</strong> analogues against human herpesvirus 6. Antiviral Res 28, 343-357. Rezk, S. A. & Weiss, L. M. (2007). Epstein-Barr virus-associated lymphoproliferative disor<strong>de</strong>rs. Hum Pathol 38, 1293-1304. Robinson, B., Turchan, J., An<strong>de</strong>rson, C., Chauhan, A. & Nath, A. (2006). Modulation of human immuno<strong>de</strong>ficiency virus infection by anticonvulsant drugs. J Neurovirol 12, 1-4. Rojo, J., Ferrer Argote, V. E., Klueppelberg, U., Krueger, G. R., Eidt, E., Ablashi, D. V., Luka, J. & Tesch, H. (1994). Semi-quantitative in situ hybridization and immunohistology for antigen expression of human herpesvirus-6 in various lymphoproliferative diseases. In Vivo 8, 517-526. Rotola, A., Ravaioli, T., Gonelli, A., Dewhurst, S., Cassai, E. & Di Luca, D. (1998). U94 of human herpesvirus 6 is expressed in latently infected peripheral blood mononuc<strong>le</strong>ar cells and blocks viral gene expression in transformed lymphocytes in culture. Proc Natl Acad Sci U S A 95, 13911-13916. Rowlings, P. A., Curtis, R. E., Passweg, J. R., Deeg, H. J., Socie, G., Travis, L. B., Kingma, D. W., Jaffe, E. S., Sobocinski, K. A. & Horowitz, M. M. (1999). Increased inci<strong>de</strong>nce of Hodgkin's disease after allogeneic bone marrow transplantation. J Clin Oncol 17, 3122- 3127. Safronetz, D., Petric, M., Tellier, R., Parvez, B. & Tipp<strong>le</strong>s, G. A. (2003). Mapping ganciclovir resistance in the human herpesvirus-6 U69 protein kinase. J Med Virol 71, 434-439. Salahuddin, S. Z., Ablashi, D. V., Markham, P. D., Josephs, S. F., Sturzenegger, S., Kaplan, M., Halligan, G., Biberfeld, P., Wong-Staal, F., Kramarsky, B. & et al. (1986). Isolation of a new virus, HBLV, in patients with lymphoproliferative disor<strong>de</strong>rs. Science 234, 596-601. Salonen, M. J., Siimes, M. A., Salonen, E. M., Vaheri, A. & Koskiniemi, M. (2002). Antibody status to HHV-6 in children with <strong>le</strong>ukaemia. Leukemia 16, 716-719. Sanchez-Beato, M., Sanchez, E., Garcia, J. F., Perez-Rosado, A., Montoya, M. C., Fraga, M., Artiga, M. J., Navarrete, M., Abraira, V., Morente, M., Estel<strong>le</strong>r, M., Koseki, H., Vidal, M. & Piris, M. A. (2004). Abnormal PcG protein expression in Hodgkin's lymphoma. Relation with E2F6 and NFkappaB transcription factors. J Pathol 204, 528- 537. Sandor, V., Bakke, S., Robey, R. W., Kang, M. H., Blagosklonny, M. V., Ben<strong>de</strong>r, J., Brooks, R., Piekarz, R. L., Tucker, E., Figg, W. D., Chan, K. K., Goldspiel, B., Fojo, A. T., Balcerzak, S. P. & Bates, S. E. (2002). Phase I trial of the histone <strong>de</strong>acetylase inhibitor, <strong>de</strong>psipepti<strong>de</strong> (FR901228, NSC 630176), in patients with refractory neoplasms. Clin Cancer Res 8, 718-728. Santoro, F., Kennedy, P. E., Locatelli, G., Malnati, M. S., Berger, E. A. & Lusso, P. (1999). CD46 is a cellular receptor for human herpesvirus 6. Cell 99, 817-827. Scheeren, F. A., Diehl, S. A., Smit, L. A., Beaumont, T., Naspetti, M., Ben<strong>de</strong>, R. J., Blom, B., Karube, K., Ohshima, K., van Noesel, C. J. & Spits, H. (2008). IL-21 is expressed in 176
Hodgkin lymphoma and activates STAT5: evi<strong>de</strong>nce that activated STAT5 is required for Hodgkin lymphomagenesis. Blood 111, 4706-4715. Schirmer, E. C., Wyatt, L. S., Yamanishi, K., Rodriguez, W. J. & Frenkel, N. (1991). Differentiation between two distinct classes of viruses now classified as human herpesvirus 6. Proc Natl Acad Sci U S A 88, 5922-5926. Sch<strong>le</strong>imann, M. H., Mol<strong>le</strong>r, J. M., Kofod-Olsen, E. & Hollsberg, P. (2009). Direct Repeat 6 from human herpesvirus-6B enco<strong>de</strong>s a nuc<strong>le</strong>ar protein that forms a comp<strong>le</strong>x with the viral DNA processivity factor p41. PLoS One 4, e7457. Schmidt, C. A., Oett<strong>le</strong>, H., Peng, R., Bin<strong>de</strong>r, T., Wilborn, F., Huhn, D., Siegert, W. & Herbst, H. (2000). Presence of human beta- and gamma-herpes virus DNA in Hodgkin's disease. Leuk Res 24, 865-870. Schnei<strong>de</strong>r, E. M., Torlakovic, E., Stuh<strong>le</strong>r, A., Diehl, V., Tesch, H. & Giebel, B. (2004). The early transcription factor GATA-2 is expressed in classical Hodgkin's lymphoma. J Pathol 204, 538-545. Schwab, U., Stein, H., Ger<strong>de</strong>s, J., Lemke, H., Kirchner, H., Schaadt, M. & Diehl, V. (1982). Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 299, 65-67. Schwering, I., Brauninger, A., K<strong>le</strong>in, U., Jungnickel, B., Tinguely, M., Diehl, V., Hansmann, M. L., Dalla-Favera, R., Rajewsky, K. & Kuppers, R. (2003). Loss of the B-lineagespecific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 101, 1505-1512. Seishima, M., Yamanaka, S., Fujisawa, T., Tohyama, M. & Hashimoto, K. (2006). Reactivation of human herpesvirus (HHV) family members other than HHV-6 in druginduced hypersensitivity syndrome. Br J Dermatol 155, 344-349. Seitz, V., Hummel, M., Marafioti, T., Anagnostopoulos, I., Assaf, C. & Stein, H. (2000). Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease. Blood 95, 3020-3024. Sekine, N., Motokura, T., Oki, T., Umeda, Y., Sasaki, N., Hayashi, M., Sato, H., Fujita, T., Kaneko, T., Asano, Y. & Kikuchi, K. (2001). Rapid loss of insulin secretion in a patient with fulminant <strong>type</strong> 1 diabetes mellitus and carbamazepine hypersensitivity syndrome. JAMA 285, 1153-1154. Shanavas, K. R., Kala, V., Vasu<strong>de</strong>van, D. M., Vijayakumar, T. & Yadav, M. (1992). Anti- HHV-6 antibodies in normal population and in cancer patients in India. J Exp Pathol 6, 95-105. Shaw, R. N., Arbiser, J. L. & Offermann, M. K. (2000). Valproic acid induces human herpesvirus 8 lytic gene expression in BCBL-1 cells. AIDS 14, 899-902. Shear, N. H. & Spielberg, S. P. (1988). Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest 82, 1826-1832. Shiohara, T., Iijima, M., Ikezawa, Z. & Hashimoto, K. (2007). The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol 156, 1083-1084. Shiohara, T., Inaoka, M. & Kano, Y. (2006). Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a comp<strong>le</strong>x interplay among herpesviruses and antiviral and antidrug immune responses. Al<strong>le</strong>rgol Int 55, 1-8. Shiohara, T. & Kano, Y. (2007). A comp<strong>le</strong>x interaction between drug al<strong>le</strong>rgy and viral infection. Clin Rev Al<strong>le</strong>rgy Immunol 33, 124-133. Shiramizu, B., Chang, C. W. & Cairo, M. S. (2001). Absence of human herpesvirus-6 genome 177
- Page 1:
UNIVERSITE DE LIMOGES ECOLE DOCTORA
- Page 4 and 5:
Sommaire Liste des figures p.7 List
- Page 6 and 7:
VI.2. Nouvelles approches p.71 Trav
- Page 8 and 9:
Liste des tableaux Tableau 1 Caract
- Page 10 and 11:
IE immediate early Ig immunoglobuli
- Page 12 and 13:
Sous-famille Virus Alphaherpesvirin
- Page 14 and 15:
Environnement bibliographique Parti
- Page 16 and 17:
II.2. Génome Le génome d’HHV-6
- Page 18 and 19:
U2-U19 U27-U37 U38-U40 U41-U46 U48-
- Page 20 and 21:
sont détectés environ 3h après l
- Page 22 and 23:
IV.4. Encapsidation Les signaux sp
- Page 24 and 25:
V. Effets du virus sur la cellule h
- Page 26 and 27:
VII. Physiopathologie de l’infect
- Page 28 and 29:
présence d’ADN de l’HHV-6 dans
- Page 30 and 31:
IX. 2. Infection des immunodéprim
- Page 32 and 33:
détails ultérieurement. De façon
- Page 34 and 35:
a b Figure 6 : Effet cytopathogène
- Page 36 and 37:
XI.1. Analogues nucléosidiques L
- Page 38 and 39:
Acyclovir (Zovirax ®) Valacyclovir
- Page 40 and 41:
Partie 2 : Le syndrome d’hypersen
- Page 42 and 43:
jours, et pouvant atteindre 38 à 4
- Page 44 and 45:
Carbamazépine, phénytoïne, valpr
- Page 46 and 47:
III. Implication virale Une étroit
- Page 48 and 49:
sus-citées (figure 11). Des travau
- Page 50 and 51:
La reconnaissance du syndrome le pl
- Page 52 and 53:
A B Figure 12 : Coupe histologique
- Page 54 and 55:
lymphome nodulaire est surtout fré
- Page 56 and 57:
maladie indolente avec des récidiv
- Page 58 and 59:
Facteurs associés à un pronostic
- Page 60 and 61:
Les cellules HRS présentent un imm
- Page 62 and 63:
IV.3. Dérégulation de l’express
- Page 64 and 65:
Figure 15 : Reprogrammation génét
- Page 66 and 67:
Un gain génétique est également
- Page 68 and 69:
transgéniques exprimant LMP1 déve
- Page 70 and 71:
Références Méthode de détection
- Page 72 and 73:
supprimer l’expression de la prot
- Page 74 and 75:
Partie 1 : Etude du rôle de l’HH
- Page 76 and 77:
Drogue Charge virale Figure 17 : D
- Page 78 and 79: Dilution du stock viral Volume de s
- Page 80 and 81: Acide valproïque Carbamazépine Ph
- Page 82 and 83: IV. Article 2 Amoxicillin-induced f
- Page 84 and 85: % viabilité cellulaire 140 120 100
- Page 86 and 87: VI. Etude d’une cohorte de patien
- Page 88 and 89: VII. Article 3 Drug Reaction with E
- Page 90 and 91: de monocytoses ou de lymphadénopat
- Page 92 and 93: Nombre de copie de EBNA1 (% contrô
- Page 94 and 95: injectées à des souris immunodép
- Page 96 and 97: Au sein du laboratoire de microbiol
- Page 98 and 99: égion V du gène des immunoglobuli
- Page 100 and 101: IV. Article 4 Involvement of human
- Page 102 and 103: I. Discussion des articles 4 et 5 L
- Page 104 and 105: Récepteur Cytoplasme Figure 24 : M
- Page 106 and 107: Conclusions - perspectives Ce trava
- Page 108 and 109: moindre importance. Il serait inté
- Page 110 and 111: perte relative du programme d’exp
- Page 112 and 113: d’orienter la recherche de déré
- Page 114 and 115: Alexander, F. E., Jarrett, R. F., L
- Page 116 and 117: D. V. & DiPaolo, J. A. (1994a). Hum
- Page 118 and 119: Lancet 2, 390. Dutton, A., Reynolds
- Page 120 and 121: herpesvirus 6 (HHV6) and human herp
- Page 122 and 123: in the IkappaBalpha gene in the mal
- Page 124 and 125: development in human germinal centr
- Page 126 and 127: (HHV-6) variant A from a parent to
- Page 130 and 131: y polymerase chain reaction in chil
- Page 132 and 133: Torlakovic, E., Tierens, A., Dang,
- Page 134 and 135: Young, L. S. & Murray, P. G. (2003)